Scherf H R
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Dec 9;87(3):327-32. doi: 10.1007/BF00506506.
The carcinogenic substance 4-dimethylaminoazobenzene and the non-carcinogen azobenzene were administered orally once a day to male Sprague-Dawley rats over several weeks at an equimolar dosage of 5-10(-5) moles/kg. Their immunological properties were examined in four different tests. The two substances suppress the cellular immune reactions of the rats already during the first month of treatment. The degree of efficiency of the immunosuppressive property decrease with the degree of antigenicity of the test antigen. Even a two-month treatment of the animals with the two substances had no evident influence on antibody formation. Correlations between the immune response and the carcinogenic effect were not demonstrable.
将致癌物质4-二甲基氨基偶氮苯和非致癌物质偶氮苯,以5×10⁻⁵摩尔/千克的等摩尔剂量,每天一次口服给予雄性斯普拉格-道利大鼠,持续数周。通过四项不同的试验检测它们的免疫学特性。在治疗的第一个月内,这两种物质就已开始抑制大鼠的细胞免疫反应。免疫抑制特性的效率程度随测试抗原的抗原性程度而降低。用这两种物质对动物进行为期两个月的治疗,对抗体形成也没有明显影响。未发现免疫反应与致癌作用之间存在相关性。